These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17178444)

  • 1. Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material.
    Dai WG; Dong LC; Li S; Pollock-Dove C; Chen J; Mansky P; Eichenbaum G
    Int J Pharm; 2007 May; 336(1):1-11. PubMed ID: 17178444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method for screening of solid dispersion formulations of low-solubility compounds--miniaturization and automation of solvent casting and dissolution testing.
    Shanbhag A; Rabel S; Nauka E; Casadevall G; Shivanand P; Eichenbaum G; Mansky P
    Int J Pharm; 2008 Mar; 351(1-2):209-18. PubMed ID: 18054181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
    Dai WG; Pollock-Dove C; Dong LC; Li S
    Adv Drug Deliv Rev; 2008 Mar; 60(6):657-72. PubMed ID: 18222563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of oral bioavailability enhancing formulations during drug discovery.
    Zheng W; Jain A; Papoutsakis D; Dannenfelser RM; Panicucci R; Garad S
    Drug Dev Ind Pharm; 2012 Feb; 38(2):235-47. PubMed ID: 21851310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study.
    Li S; Pollock-Dove C; Dong LC; Chen J; Creasey AA; Dai WG
    Mol Pharm; 2012 May; 9(5):1100-8. PubMed ID: 22376012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
    Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound.
    Sigfridsson K; Forssén S; Holländer P; Skantze U; de Verdier J
    Eur J Pharm Biopharm; 2007 Sep; 67(2):540-7. PubMed ID: 17383167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM; Kellaway IW; Murdan S
    J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ; Xu GX
    Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
    Wang S; Sun M; Ping Q
    Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
    Li DX; Han MJ; Balakrishnan P; Yan YD; Oh DH; Joe JH; Seo Y; Kim JO; Park SM; Yong CS; Choi HG
    Arch Pharm Res; 2010 Jan; 33(1):95-101. PubMed ID: 20191350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds.
    Araya H; Tomita M; Hayashi M
    Int J Pharm; 2005 Nov; 305(1-2):61-74. PubMed ID: 16219433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.
    Kennedy M; Hu J; Gao P; Li L; Ali-Reynolds A; Chal B; Gupta V; Ma C; Mahajan N; Akrami A; Surapaneni S
    Mol Pharm; 2008; 5(6):981-93. PubMed ID: 19434920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X; Barone MR; Marsac PJ; Sperry DC
    Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability.
    Childs SL; Kandi P; Lingireddy SR
    Mol Pharm; 2013 Aug; 10(8):3112-27. PubMed ID: 23822591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone.
    Sek L; Boyd BJ; Charman WN; Porter CJ
    J Pharm Pharmacol; 2006 Jun; 58(6):809-20. PubMed ID: 16734982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
    Vandecruys R; Peeters J; Verreck G; Brewster ME
    Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.